On Monday, Ontario’s associate chief medical officer of health Dr. Barbara Yaffe reported the province faced a total of 14 total cases of blood clotting due to the AstraZeneca COVID-19 vaccine, 10 of which are vaccine-induced thrombotic thrombocytopenia (VITT). Ontario recently put a pause on administering the first dose of the AstraZeneca vaccine due to the extremely rare blood clotting disorder, but will offer second doses to those who want one.
Canada
Ontario reports total of 14 blood-clotting cases due to AstraZeneca COVID-19 vaccine
More Videos
-
ICE taps Ontario firm for 20 armoured vehicles
-
‘Titanic was sinking,’ Ford says he was aware of Algoma Steel layoffs before 100M loan
-
Crown Royal maker reaches deal with union over Ontario plant closure
-
Snow warnings in place for Ontario. Here’s what to expect
-
Ottawa, B.C. unveil anti-extortion measures
-
‘It’s a joke’: Ford reacts to concerns that speed signs are too big
You are viewing an Accelerated Mobile Webpage.
View Original Article